Issued Patents All Time
Showing 1–25 of 35 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12258409 | Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies | Gordon J. Freeman, Vassiliki Boussiotis, Xia Bu, Vikram Juneja, Nikolaos Patsoukis +2 more | 2025-03-25 |
| 12186278 | Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy | Jennifer Brogdon, Hwai Wen Chang, Boris Engels, Gordon J. Freeman, Gerhard Frey +2 more | 2025-01-07 |
| 11827704 | Antibody molecules to PD-1 and uses thereof | Gordon J. Freeman, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more | 2023-11-28 |
| 11685782 | Methods of treating cancer using LSD1 inhibitors in combination with immunotherapy | Yang Shi, Wanqiang Sheng, Martin W. LaFleur | 2023-06-27 |
| 11492403 | Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof | Gordon J. Freeman, Vassiliki Boussiotis, Xia Bu, Vikram Juneja, Nikolaos Patsoukis +2 more | 2022-11-08 |
| 11413340 | Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy | Jennifer Brogdon, Hwai Wen Chang, Boris Engels, Gordon J. Freeman, Gerhard Frey +2 more | 2022-08-16 |
| 11359013 | Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway | Gordon J. Freeman, David M. Dorfman, Rafi Ahmed, Daniel Barber, E. John Wherry | 2022-06-14 |
| 11359020 | Agents that modulate immune cell activation and methods of use thereof | Gordon J. Freeman, Yanping Xiao, Loise M. Francisco, Rosemarie Dekruyff, Dale T. Umetsu | 2022-06-14 |
| 11207393 | Regulatory T cell PD-1 modulation for regulating T cell effector immune responses | Gordon J. Freeman, Loise M. Francisco, Peter T. Sage, Sun-Jong Lee, Scott B. Lovitch +2 more | 2021-12-28 |
| 11124569 | Methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 Fc fusion proteins that bind Fc receptors | Gordon J. Freeman, Rafi Ahmed, Masao Hashimoto, Hyun T. Jin | 2021-09-21 |
| 11028364 | Compositions and methods for modulating an immune response | Peter T. Sage | 2021-06-08 |
| 10934353 | Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use | Gordon J. Freeman | 2021-03-02 |
| 10927410 | Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators | William N. Haining, Jernej Godec | 2021-02-23 |
| 10851165 | Antibody molecules to PD-L1 and methods of treating cancer | Gordon J. Freeman, Gerhard Frey, Hwai Wen Chang, Jennifer Marie Mataraza, Glenn Dranoff | 2020-12-01 |
| 10752687 | Antibody molecules to PD-1 and uses thereof | Gordon J. Freeman, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more | 2020-08-25 |
| 10653123 | Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo | William N. Haining, Jernej Godec | 2020-05-19 |
| 10577586 | Compositions and methods for modulating an immune response | Peter T. Sage, Loise M. Francisco | 2020-03-03 |
| 10457733 | Agents that modulate immune cell activation and methods of use thereof | Gordon J. Freeman, Yanping Xiao, Loise M. Francisco, Rosemarie Dekruyff, Dale T. Umetsu | 2019-10-29 |
| 10370446 | Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway | Gordon J. Freeman, David M. Dorfman, Rafi Ahmed, Daniel Barber, E. John Wherry | 2019-08-06 |
| 10202454 | Anti-PD-L1 monoclonal antibodies and fragments thereof | Gordon J. Freeman | 2019-02-12 |
| 9988452 | Antibody molecules to PD-L1 and uses thereof | Gordon J. Freeman, Gerhard Frey, Hwai Wen Chang, Jennifer Marie Mataraza, Glenn Dranoff | 2018-06-05 |
| 9885016 | Compositions and methods for modulating an immune response | Peter T. Sage, Loise M. Francisco | 2018-02-06 |
| 9845356 | Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use | Gordon J. Freeman | 2017-12-19 |
| 9815898 | Antibody molecules to PD-1 and uses thereof | Gordon J. Freeman, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more | 2017-11-14 |
| 9683048 | Antibody molecules to PD-1 and uses thereof | Gordon J. Freeman, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more | 2017-06-20 |